ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

From Oncology Today with Dr Neil Love by Dr. Neil Love

April 14, 2026 · 58 min · Season 26 · Episode 223

About this episode

Dr Virginia F Borges and Dr Ian E Krop discuss first-line and maintenance therapy for ER-positive, HER2-positive metastatic breast cancer.

Dr Virginia F Borges from the University of Colorado Anschutz Medical Campus in Aurora and Dr Ian E Krop from Yale Cancer Center in New Haven, Connecticut, review clinical research data and best practices guiding the selection of first-line and maintenance therapy for patients with ER-positive, HER2-positive metastatic breast cancer. CME information and select publications here .

People in this episode

Host: Dr. Neil Love

Guests: Dr Virginia F Borges, Dr Ian E Krop

Topics covered

  • metastatic breast cancer
  • first-line therapy
  • maintenance therapy
  • clinical research
  • best practices

Keywords

  • ER-positive
  • HER2-positive
  • metastatic breast cancer
  • first-line therapy
  • maintenance therapy
  • clinical research
  • best practices

Mentioned in this episode

Organizations: University of Colorado Anschutz Medical Campus, Yale Cancer Center

More episodes of Oncology Today with Dr Neil Love

Explore listener stats, chart rankings, contacts and more on the Oncology Today with Dr Neil Love podcast page.